Corrigendum to "Dissolvable microarray patches of levodopa and carbidopa for Parkinson's disease management" [Eur. J. Pharm. Biopharm. 199 (2024) 114304].
Corrigendum to "Dissolvable microarray patches of levodopa and carbidopa for Parkinson's disease management" [Eur. J. Pharm. Biopharm. 199 (2024) 114304].
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Belfast, GB · Author affiliation
School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK; Fakultas Farmasi, Universitas Megarezky, Jl. Antang Raya No. 43, Makassar 90234, Indonesia.Location evidence
Lisburn, GB · Author affiliation
School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK; Fakultas Farmasi, Universitas Megarezky, Jl. Antang Raya No. 43, Makassar 90234, Indonesia.Location evidence
Makassar, ID · Author affiliation
School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, UK; Fakultas Farmasi, Universitas Megarezky, Jl. Antang Raya No. 43, Makassar 90234, Indonesia.Location evidence
Bucaramanga, CO · Author affiliation
Basic Science Department, Faculty of Health, Universidad Industrial de Santander, Bucaramanga 680001, Colombia.Location evidence
Publication status: correction_notice
A plain-language reading has not been prepared for this paper yet.